期刊文献+

原发性胆囊癌中PTEN和P53基因表达的研究 被引量:1

Study on the expression of PTEN and P53 in human primary gallbladder carcinoma(HGC)
下载PDF
导出
摘要 背景与目的:研究PTEN和P53基因在原发性胆囊癌(HGC)中的表达,以探讨它们在HGC发生发展中的作用,寻找胆囊癌诊断及预后的指标。方法:应用原位杂交(DNA-RNA)技术与免疫组化SP法分别检测64例HGC中PTEN mRNA、PTEN蛋白和P53蛋白的表达。以22例胆囊腺瘤及10例慢性胆囊炎作为对照。结果:①PTEN mRNA和蛋白在HGC组织中的阳性率(56.3%,59.4%)均明显低于胆囊腺瘤组织(81.8%,90.8%)和慢性胆囊炎组织(100%,100%),(P<0.05)。②P53蛋白在HGC组织中的阳性率(62.2%)均明显高于胆囊腺瘤组织(27.2%)和慢性胆囊炎组织(0.0%),(P<0.05)。结论:PTEN缺失和P53突变型蛋白共同参与了HGC的发生发展。 Background and purpose: To study the expression of PTEN and P53 and analyse their roles in HGC oncogenesis , and to discover a good marker for diagnosis and prognosis of HGC. Methods: The expression of PTEN mRNA, PTEN protein and P53 protein were detected by in situ hybridization(DNA-RNA) and immunohistochemistry( SP method) in 64 cases of HGC. We took 22 cases of gallbladder adenoma and 10 cases of chronic cholecystitis as controls. Results: (1) The positive expression rates of PTEN mRNA and protein in HGC( 56.3%, 59.4% ) were significantly lower than that in gallbladder adenoma (81.8%, 90.8% ) and chronic cholecystitis( 100%, 100% ) ( P 〈 0.05). (2) The positive expression rates of P53 protein in HGC(62.2%) were significantly higher than those in gallbladder adenoma (27.2%) and chronic cholecystitis (0.0%) (P 〈0.05). Conclusions: PTEN and, P53 may play important roles in HGC oncogenesis.
作者 黄英 郑长黎
出处 《中国癌症杂志》 CAS CSCD 2006年第7期547-550,共4页 China Oncology
关键词 原发性胆囊癌 P53 PTEN 免疫组化 原位杂交 primary gallbladder carcinoma P53 PTEN immunochemistry in situ hybridization
  • 相关文献

参考文献1

二级参考文献25

  • 1Li J,Yen C,Liaw D, et al .Science, 1997,275:1943-1947.
  • 2Steck PA,Pershous MA,Japer SA, et al .Nat Genet,1997,15:356.
  • 3Li DM,Sun H.Cancer Res, 1997,57:2124-2129.
  • 4Myers MP, Stolarov JP, Eng C, et al . Proc Natl Acad Sci USA, 1997,94: 9052-9057.
  • 5Furnari FB,Lin H, Huang H, et al. Proc Natl Acad Sci USA,1997,94:12479-12484.
  • 6Robertson GP, Furnari FB,Miele ME, et al .Proc Natl Acad Sci USA,1998,95: 9418-9423.
  • 7Kulik G,Weber MJ.Mol Cell Bio1,1998,18:6711-6718.
  • 8Maehama T, Dixon JE.Trends Cell Bio1,1999,9(4):125-128.
  • 9Davies MA,Koul D, Dhesi H, et al .Cancer Res, 1999,59:2551-2556.
  • 10Besson A,Robbins SM,Yong VW. Eur J Biochem,1999,263(3):605.

共引文献2

同被引文献7

  • 1智绪亭,李亮,张宗利,魏其珍,曲辉.Survivin在胆囊癌中的表达及其与p53相关性研究[J].中华肝胆外科杂志,2006,12(12):844-846. 被引量:3
  • 2Tch M, Wcc A, Raju G C, et al. An immunohistcehemical study of p53 protein in gallbladder and extrahepatic bile duct lampullary carcinoma. Cancer, t994,74(5) : 1542
  • 3Adida C, Crotty P L, McGrath J, et al. Developmentally regulated expression of the novel cancer anti - apoptosis gene survivin in human and mouse differentiation. Am J Pathol, 1998, 152(1): 43
  • 4Kren, Leos, Brazdil. Prognostic significance of anti - apoptosis proteins survivin and bcl - 2 in non - small cell lung carcinomas: A clinicopathologic study of 102 eases. Appl lmmunohistcehem Mol Morphol, 2004, 12:44
  • 5Suzuki A, Ito T, Kawano H, et al. Survivin initates ptroeaspsae3/P21 complex fonnation as a.result of interaction with CDK4 to resist Fasmedinted cell death. Oncoge, 2000, 19(10): 1346
  • 6Ikeguehi M, Ueda T, Sakatani T, et al. Expression of survivin messenger RNA correlates with poor prognosis in patient with hepatocellular earcinoma. Diagn Mcl Patghol, 2002, 11 ( 1 ) : 33
  • 7Ikeguehi M, Kaibara N. Survivin messenger RNA expression is a good prognostic biom arker for oesophageal carcinoma. Br J Cancer, 2002, 87 (8): 883

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部